Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds Post author: Post published:February 9, 2024 Post category:uncategorized The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR). You Might Also Like A single immune protein may help explain why kidney and heart disease often develop together January 6, 2026 WPI researcher receives NSF CAREER Award to create bioadhesives for medical applications April 9, 2025 New yeast model sheds light on proteasome and mitochondrial interaction June 30, 2025
A single immune protein may help explain why kidney and heart disease often develop together January 6, 2026
WPI researcher receives NSF CAREER Award to create bioadhesives for medical applications April 9, 2025